Healius will be in a “material net cash position’’ following the sale of its Lumus Imaging division for $965m, and will ...

In October 2023, RAC contracted Attentive Science (USA) and Agilex Biolabs (Australia) to undertake the regulatory-standard GLP non-clinical toxicology and safety pharmacology studies required to ...

Healius Ltd. agreed to sell its Lumus imaging unit to a private equity group for A$965 million ($657 million), as the ...

Altera today shared new details about Agilex 3, an upcoming series of chips optimized to power connected devices and factory automation systems. The Intel Corp. unit first previewed the processor ...

These new service capabilities leverage SGS’s global partnership with Australian bioanalytical testing specialists, Agilex Biolabs. The addition of the Hudson lab expands the SGS global ...

Agilex Biolabs’s revenue soared nearly 21 per cent to $39.5m. On the outlook, Healius said volume growth in pathology continued in July and August, up 4 per cent on the previous period.

as well as its Agilex Biolabs division. “Following completion of the transaction, Healius will continue to be a leading provider of pathology services in Australia with a rapidly growing ...